Orange Book product · Generic (ANDA)
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Generic (ANDA)ANDA 074654DISCN SANDOZ
At a glance
Dec 31, 1996
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 31, 1996
29 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Strength
385MG;30MG;25MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 074654
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
